Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 3/20 | 0.47 |
| ▸ | LTA4H | P09960 | 2/20 | 0.47 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.40 |
| ▸ | FAAH | O00519 | 5/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4579086 | 0.95 | PDK2 (0.45) | PDK2LTA4HPTPN11MAPTNR5A1 | |
| SCHEMBL988298 | 0.95 | PDK2 (0.45) | PDK2LTA4HPTPN11MAPTNR5A1 | |
| SCHEMBL12628268 | 0.90 | DRD2 (0.43) | PDK2LTA4HPTPN11MAPTNR5A1 | |
| SCHEMBL30673176 | 0.90 | PDK2 (0.49) | PDK2LTA4HPTPN11MAPTTP53 | |
| SCHEMBL12107998 | 0.89 | PDK2 (0.44) | PDK2LTA4HPTPN11MAPTNR5A1 | |
| SCHEMBL12107999 | 0.89 | NR5A1 (0.57) | PDK2LTA4HPTPN11MAPTNR5A1 | |
| SCHEMBL21944336 | 0.89 | MAPT (0.42) | PDK2LTA4HMAPTNR5A1TP53 | |
| SCHEMBL16502180 | 0.88 | SMN1; SMN2 (0.46) | PDK2MAPTNR5A1TP53PLA2G4B | |
| SCHEMBL12108048 | 0.88 | TSHR (0.42) | PDK2LTA4HMAPTNR5A1TP53 | |
| SCHEMBL12108042 | 0.86 | PDK2 (0.39) | PDK2MAPTNR5A1TP53TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1558696-B1 | NEW METHOD FOR THE PRODUCTION OF MONOMERS USEFUL IN THE MANUFACTURE OF SEMICONDUCTIVE POLYMERS | MERCK PATENT GMBH (DE) | 2009-09-23 | — | — | EP | disclosed |
| US-7368616-B2 | Method for the production of monomers useful in the manufacture of semiconductive polymers | MERCK PATENT GMBH (DE) | 2008-05-06 | — | — | US | disclosed |
| US-7368616-B2 | Method for the production of monomers useful in the manufacture of semiconductive polymers | MERCK PATENT GMBH (DE) | 2008-05-06 | — | — | US | disclosed |
| US-7368616-B2 | Method for the production of monomers useful in the manufacture of semiconductive polymers | MERCK PATENT GMBH (DE) | 2008-05-06 | — | — | US | disclosed |
| US-20050240011-A1 | Method for the prodution of monomers useful in the manufacture of semiconductive polymers | COVION ORGANIC SEMICONDUCTORS GMBH (DE) | 2005-10-27 | — | — | US | disclosed |
| EP-1416028-A1 | New method for the production of monomers useful in the manufacture of semiconductive polymers | Covion Organic Semiconductors GmbH (DE) | 2004-05-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050240011-A1 | Method for the prodution of monomers useful in the manufacture of semiconductive polymers | INF2, PARN, MACF1 | PDK2 2569/4885LTA4H 1904/4885PTPN11 4833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.